Skip to main content
TipRanks
Go Ultimate75% OFF

Active Biotech AB (ACTI) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

Active Biotech AB has a market cap or net worth of SEK 92.53M. The enterprise value is SEK 67.83M.

Market Cap
SEK 92.53M
Enterprise Value
SEK 67.83M

Share Statistics

Active Biotech AB has 26,360,670 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
26,360,670
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Active Biotech AB’s return on equity (ROE) is -0.67 and return on invested capital (ROIC) is -65.61%.

Return on Equity (ROE)
-0.67
Return on Assets (ROA)
-0.53
Return on Invested Capital (ROIC)
-65.61%
Return on Capital Employed (ROCE)
-0.68
Revenue Per Employee
0
Profits Per Employee
-7.46M
Employee Count
5
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Active Biotech AB is -5.01. Active Biotech AB’s PEG ratio is 0.01.

PE Ratio
-5.01
PS Ratio
0.00
PB Ratio
3.21
Price to FCF
-2.95
Price to Operating Cash Flow
-2.95
PEG Ratio
0.01

Income Statement

In the last 12 months, Active Biotech AB had revenue of 0 and earned -37.30M in profits. Earnings per share was -0.03.

Revenue
0
Gross Profit
-1.60M
Operating Income
-37.60M
Pretax Income
-37.30M
Net Income
-37.30M
EBITDA
-36.00M
Earnings Per Share (EPS)
-0.03

Cash Flow

In the last 12 months, operating cash flow was -31.40M and capital expenditures 7.20M, giving a free cash flow of -31.40M billion.

Operating Cash Flow
-31.40M
Free Cash Flow
-31.40M
Free Cash Flow per Share
-1.19

Dividends & Yields

Active Biotech AB pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-34.03%
Earnings Yield
-38.91%

Stock Price Statistics

Beta
0.11
52-Week Price Change
-41.09%
50-Day Moving Average
3.81
200-Day Moving Average
5.13
Relative Strength Index (RSI)
45.00
Average Volume (3m)
56.21K

Important Dates

Active Biotech AB upcoming earnings date is Feb 11, 2027, Before Open (Not Confirmed).

Last Earnings Date
Nov 05, 2026
Next Earnings Date
Feb 11, 2027
Ex-Dividend Date
―

Financial Position

Active Biotech AB as a current ratio of 4.66, with Debt / Equity ratio of 3.12%

Current Ratio
4.66
Quick Ratio
4.66
Debt to Market Cap
0.00
Net Debt to EBITDA
1.76
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, Active Biotech AB has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Active Biotech AB EV to EBITDA ratio is -1.61, with an EV/FCF ratio of -1.78.

EV to Sales
0.00
EV to EBITDA
-1.61
EV to Free Cash Flow
-1.78
EV to Operating Cash Flow
-1.78

Balance Sheet

Active Biotech AB has SEK 36.30M in cash and marketable securities with SEK 0.00 in debt, giving a net cash position of SEK 36.30M billion.

Cash & Marketable Securities
SEK 36.30M
Total Debt
SEK 0.00
Net Cash
SEK 36.30M
Net Cash Per Share
SEK 1.38
Tangible Book Value Per Share
SEK 1.08

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for Active Biotech AB is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
―
EPS Growth Forecast
51.09%

Scores

Smart Score
―
AI Score
44